TNF Pharmaceuticals Inc（TNFA）の財務TNFATNF Pharmaceuticals Inc

Evaluating the bottom line, TNF Pharmaceuticals Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -413.96%, provide a clear picture of how effectively TNFA converts its operational activities into shareholder value.

In the context of the broader market, TNFA competes directly with industry leaders such as SNOA and SBFM. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, TNFA's gross margin of N/A stands against SNOA's 40.23% and SBFM's 25.35%. Such benchmarking helps identify whether TNF Pharmaceuticals Inc is trading at a premium or discount relative to its financial performance.